BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33685989)

  • 1. Targeting Mitochondrial Iron Metabolism Suppresses Tumor Growth and Metastasis by Inducing Mitochondrial Dysfunction and Mitophagy.
    Sandoval-Acuña C; Torrealba N; Tomkova V; Jadhav SB; Blazkova K; Merta L; Lettlova S; Adamcová MK; Rosel D; Brábek J; Neuzil J; Stursa J; Werner L; Truksa J
    Cancer Res; 2021 May; 81(9):2289-2303. PubMed ID: 33685989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells.
    Sohoni S; Ghosh P; Wang T; Kalainayakan SP; Vidal C; Dey S; Konduri PC; Zhang L
    Cancer Res; 2019 May; 79(10):2511-2525. PubMed ID: 30902795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine inhibits iron-uptake stimulated osteoclast differentiation by suppressing electron transport chain and MAPKs signaling.
    Zhang J; Hu W; Ding C; Yao G; Zhao H; Wu S
    Toxicol Lett; 2019 Oct; 313():50-59. PubMed ID: 31238089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction.
    Lan L; Wei W; Zheng Y; Niu L; Chen X; Huang D; Gao Y; Mo S; Lu J; Guo M; Liu Y; Lu B
    Cancer Lett; 2018 Sep; 432():132-143. PubMed ID: 29906487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.
    Chen C; Wang S; Liu P
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
    Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
    Cells; 2019 May; 8(5):. PubMed ID: 31109089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
    Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
    ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.
    Jung J; Zhang Y; Celiku O; Zhang W; Song H; Williams BJ; Giles AJ; Rich JN; Abounader R; Gilbert MR; Park DM
    Cancer Res; 2019 Oct; 79(20):5218-5232. PubMed ID: 31488423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression.
    Kalainayakan SP; Ghosh P; Dey S; Fitzgerald KE; Sohoni S; Konduri PC; Garrossian M; Liu L; Zhang L
    Sci Rep; 2019 Feb; 9(1):1405. PubMed ID: 30723259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.
    Liu Z; Qiao J; Nagy T; Xiong MP
    J Control Release; 2018 Aug; 283():84-93. PubMed ID: 29792889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II.
    Wang L; Zhang X; Cui G; Chan JY; Wang L; Li C; Shan L; Xu C; Zhang Q; Wang Y; Di L; Lee SM
    Oncotarget; 2016 May; 7(22):32054-64. PubMed ID: 27081033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endolysosome Iron Chelation Inhibits HIV-1 Protein-Induced Endolysosome De-Acidification-Induced Increases in Mitochondrial Fragmentation, Mitophagy, and Cell Death.
    Halcrow PW; Kumar N; Quansah DNK; Baral A; Liang B; Geiger JD
    Cells; 2022 May; 11(11):. PubMed ID: 35681506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
    Bakalova R; Semkova S; Ivanova D; Zhelev Z; Miller T; Takeshima T; Shibata S; Lazarova D; Aoki I; Higashi T
    Oxid Med Cell Longev; 2020; 2020():6212935. PubMed ID: 33204397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
    Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
    Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
    Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
    Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters.
    Darash-Yahana M; Pozniak Y; Lu M; Sohn YS; Karmi O; Tamir S; Bai F; Song L; Jennings PA; Pikarsky E; Geiger T; Onuchic JN; Mittler R; Nechushtai R
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):10890-5. PubMed ID: 27621439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells.
    Lyons A; Coleman M; Riis S; Favre C; O'Flanagan CH; Zhdanov AV; Papkovsky DB; Hursting SD; O'Connor R
    J Biol Chem; 2017 Oct; 292(41):16983-16998. PubMed ID: 28821609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial reactive oxygen species and heme, non-heme iron metabolism.
    Ito H; Kurokawa H; Matsui H
    Arch Biochem Biophys; 2021 Mar; 700():108695. PubMed ID: 33232715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recoding the Cancer Epigenome by Intervening in Metabolism and Iron Homeostasis with Mitochondria-Targeted Rhenium(I) Complexes.
    Pan ZY; Tan CP; Rao LS; Zhang H; Zheng Y; Hao L; Ji LN; Mao ZW
    Angew Chem Int Ed Engl; 2020 Oct; 59(42):18755-18762. PubMed ID: 32634290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.